_________
false
פרפל ביוטק בע"מ
2
381
PURPLE BIOTECH LTD
Corporation no:
520031238
16195
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
04/12/2025
www.isa.gov.il
www.tase.co.il
Reference:
2025-02-096647
Time of broadcast:
15:00
15:00
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
פרפל ביוטק בע"מ תציג נתונים פרה-קליניים חדשים מפלטפורמת הנוגדן הטרי-ספציפי קפטן -3 בקונגרס השנתי של האגודה האירופית לאונקולוגיה רפואית – אימונו-אונקולוגיה 2025.
ea026840901-pr_purplebioDRAFT1_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
06/08/2024
Address:
Oppenheimer, Science Park
4
,
Rehovot
7670104
,
Israel
Tel:
03-9333121
,
03-9311321
Fax:
03-5097196
E-mail address:
ir@purple-biotech.com
Company site:
www.kitovpharma.com
Previous names of reporting entity:
KITOV PHARMA LTD, KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory:
Zadik Avital
Position of Signatory in the reporting corporation:
Director of Finance
Name of Employer Company:
Address:
Oppenheimer, Science Park
4
,
Rehovot
7670104
Telephone:
052-8882715
Facsimile:
03-5097196
E-mail:
avitalt@purple-biotech.com
1
Israel